• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Health

UCLA Health
  • About Us
    • What is UCLA Health?
    • Contact Us
    • Your Feedback
    • Accountable Care Organization
    • Awards & Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • In the Community
    • 340B Program
    • Industry Relations
    • Innovation
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    Vital SignsLinked Graphic: Subscribe to Health Newsletters
    • Contact
    • Your Feedback
    • Accountable Care Organization
    • Awards and Achievements
    • Careers
    • Careers for Physicians
    • Departments - Administrative
    • Departments - Clinical
    • Giving to UCLA Health
    • Industry Relations
    • Innovation
    • In the Community
    • 340B Program
    • Leadership
    • News Releases
    • Price Transparency
    • Social Media
    • Subscribe to UCLA Health Newsletters
  • Conditions & Treatment
    • Health Library
    • Tests & Procedures
    • Drug Interaction Checker
    • Brain & Nervous System
    • Cancer
    • Children's Health
    • Heart Disease
    • Nutrition & Wellness
    • Pregnancy & Newborns
    • Orthopedics
    • Women's Health
    • Video Library
    • Cancer
    • Cardiovascular
    • Chiropractic
    • Cosmetic Surgery
    • Ear, Nose and Throat
    • Gastrointestinal
    • General Healthcare
    • Neurological
    • Obstetrics/Gynecology
    • See all videos...
    Symptom Checker
    • Video Library
  • Locations

    Hospitals

    • Ronald Reagan UCLA Medical Center
    • UCLA Medical Center, Santa Monica
    • UCLA Mattel Children's Hospital
    • Resnick Neuropsychiatric Hospital
    • Institutes and Centers
    • Take a Virtual Tour

    Medical Offices/Clinics

    • Primary Care
    • Specialty Care
    • Urgent Care Centers
    • Outpatient Surgery Centers
    • Community Cancer Care
    • Imaging/Radiology Locations
    • Clinical Labs
    • Pharmacies

    Interactive Map

    interactive map

    • Locations Coming Soon
    • UCLA Hospitals
    • Take a Virtual Tour
    • Primary Care Practices
    • Specialty Care Practices
    • Urgent Care Centers
    • Outpatient Surgery Centers
    • Other Locations
    • Interactive Map
    • Coming Soon!
  • Medical Services
  • For Patients & Visitors
    • Directions & Parking
    • Appointments: Call, Click, Come In
    • Admissions Information
    • Preparing For Surgery
    • Patient Services
    • Security & Parking Services
    • Office of the Patient Experience
    • For International Patients
    • Lodging & Nearby Services
    • Around Westwood
    • Gift Shops & Flowers
    • Health Resources
    • Log in to myUCLAhealth
    • Billing and Insurance Information
    • Medical Records
    • Accountable Care Organization (ACO)
    • Price Transparency
    • Interactive Patient Education Videos (Emmi)
    • FAQs
    • Calendar of Events
    • Secure Email Messages
    • Share your story. Connect. Share. Improve. UCLA Health
    • Share Your Story
    • Health Publications
    • Vital Signs Newsletters
    • Health Tips for Parents
    • Contact Us
    • Appointments: Call, Click, Come in
    • Admissions Information
    • Advance Directive
    • Directions & Parking
    • Patient Services
    • Medical Records
    • myUCLAhealth
    • Smoke-Free
    • Publications
    • Health Resources
    • Around Westwood
    • Lodging
    • Preparing For Surgery
    • Patient-focused Technology Council
    • Health Forms
    • End of Life Option Act: Resources & Materials
    • Frequently Asked Questions
    • Secure Email Messages
    • Gift Shops
  • For Healthcare Professionals
    • Referring a Patient
    • Continuing Medical Education
    • Ethics Center
    • UCLA HealthLink
    • Physician to Physician Access Line (P2P)
    • David Geffen School of Medicine at UCLA
    • Clinical Informatics Fellowship
    • Academic Positions
    • Physician Careers
    • UCLA School of Dentistry
    • UCLA School of Nursing
    • Department of Nursing

    Physician Publications

    • Physicians Update
    • Clinical Updates
    • U Magazine
    • Physician to Physician Access Line (P2P)
    • Physician Careers
    • Clinical Informatics Fellowship
    • Flu Resources for Healthcare Professionals
    • Publications
  • Multimedia
    • UCLAMDCHAT Webinars
    • Community Health Program Videos
    • iTunes
    • Download Our Apps
    • Mini Med School
    • Demystifying Cancer Forum
    • TEDx UCLA Videos
    • Tips from our Physical Therapists
    • Patient Stories
    • Real Questions
    • Webinars on Demand
    • Pediatric Grand Rounds
    • Tune in to watch our health webinars
    • Community Health Program Videos
    • UCLAMDChat Webinars
    • iTunes
    • Download Our Apps
    • Mini Med School
    • Demystifying Cancer Forum
    • TEDx UCLA Videos
    • Tips From Our Physical Therapists
    • Patient Stories
    • Real Questions
    • Back Pain Management
  • Find a Provider
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

About Us

About Us

About Us

  • Contact
  • Your Feedback
  • Accountable Care Organization
    • ACO - Anthem Blue Cross PPO
      • Anthem Blue Cross PPO ACO FAQ
  • Awards and Achievements
    • UCLA Health hospitals again rank No. 1 in Los Angeles, No. 7 nationally
    • UCLA Designated a National Magnet Hospital
  • Careers
  • Careers for Physicians
  • Departments - Administrative
  • Departments - Clinical
  • Giving to UCLA Health
  • Industry Relations
  • Innovation
  • In the Community
    • Community Health
  • 340B Program
  • Leadership
    • Dr. John Mazziotta
    • Johnese Spisso
    • Dr. Kelsey Martin
  • News Releases
  • Price Transparency
  • Social Media
  • Subscribe to UCLA Health Newsletters
  • Contact
  • Your Feedback
  • Accountable Care Organization
  • Awards and Achievements
  • Careers
  • Careers for Physicians
  • Departments - Administrative
  • Departments - Clinical
  • Giving to UCLA Health
  • Industry Relations
  • Innovation
  • In the Community
  • 340B Program
  • Leadership
  • News Releases
  • Price Transparency
  • Social Media
  • Subscribe to UCLA Health Newsletters
  1. Home
  2. About Us
  3. News Releases

News Releases

Share this

Health and Behavior

UCLA researchers develop biomarker for rapid relief of major depression

09/10/2009
It is a long, slow slog to treat major depression. Many antidepressant medications are available, but no single biomarker or diagnostic test exists to predict which one is right for an individual. As a result, for more than half of all patients, the first drug prescribed doesn't work, and it can take months to figure out what does.

Now, based on the final results of a nationwide study led by UCLA, clinicians may be able to accurately predict within a week whether a particular drug will be effective by using a non-invasive test that takes less than 15 minutes to administer. The test will allow physicians to quickly switch patients to a more effective treatment, if necessary.

The study, called the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression, or BRITE-MD, measured changes in brain-wave patterns using quantitative electroencephalography (QEEG), a non-invasive, computerized measurement that recognizes specific alterations in brain-wave activity. These changes precede improvement in mood by many weeks and appear to serve as a biomarker that accurately predicts how effective a given medication will be. The study results appear in two articles published in the September issue of the journal Psychiatry Research.
 
Nine sites around the country collaborated on the study, which enrolled a total of 375 people who had been diagnosed with major depressive disorder (MDD). Each individual was given a baseline QEEG at the beginning of the trial and then prescribed the antidepressant escitalopram, commonly known as Lexapro, one of a class of drugs known as selective serotonin re-uptake inhibitors that are commonly prescribed for depression. After one week, a second QEEG was taken. The researchers examined a biomarker called the antidepressant treatment response (ATR) index — a specific change in brain-wave patterns from the baseline QEEG.

Subjects were then randomly assigned to continue with escitalopram or were given a different drug. A total of 73 patients who remained on escitalopram were tracked for 49 days to see if their results matched the prediction of the ATR biomarker. The ATR predicted both response and remission with an accuracy rate of 74 percent, much higher than any other method available. The researchers also found that they could predict whether subjects were more likely to respond to a different antidepressant, bupropion, also known as Wellbutrin XL.
 
"Until now, other than waiting, there has been no reliable method for predicting whether a medication would lead to a good response or remission," said Dr. Andrew Leuchter, professor of psychiatry at the Semel Institute for Neuroscience and Human Behavior at UCLA and lead author of the study. "And that wait can be as long as 14 weeks. So these are very exciting findings for the patient suffering from depression. The BRITE results are a milestone in our efforts to develop clinically useful biomarkers for predicting treatment response in MDD."
 
Major depressive disorder is a leading cause of disability, costing society in excess of $80 billion annually; approximately two-thirds of these costs reflect the enormous disability associated with the disorder. An estimated 15 million people in the United States experience a depressive episode each year, and nearly 17 percent of adults will experience major depression in their lifetime.
 
"BRITE study results suggest that the ATR biomarker could potentially provide the greatest clinical benefit for those patients who might be receiving a medication that is unlikely to help them," Leuchter said. "Our results suggest that it may be possible to switch these patients to a more effective treatment quickly. This would help patients and their physicians avoid the frustration, risk and expense of long and ineffective medication trials."

Leuchter noted that research has shown that depression patients who do not get better with a first treatment experience prolonged suffering, are more likely to abandon treatment altogether and may become more resistant to treatment over time.
 
"So the benefits to the individual and to society are enormous," he said.

An added benefit of the biomarker test, according to Leuchter, is that it is non-invasive, painless and fast — about 15 minutes — and only involves the placement of six electrodes around the forehead and on the earlobes.
 
Aspect Medical Systems, which developed the ATR biomarker, provided financial support for the study. Aspect also participated in the design and conduct of the study; the collection, management, analysis and interpretation of the data; and the preparation and review of the manuscript. Final approval of the form and content of the manuscript rested with the authors.

Other UCLA authors included Dr. Ian Cook, Dr. Karl S. Burgoyne and Dr. James T. McCracken. Leuchter is chair of Aspect's neuroscience advisory board and has provided scientific consultation to them.
 
The Semel Institute for Neuroscience and Human Behavior is an interdisciplinary research and education institute devoted to the understanding of complex human behavior, including the genetic, biological, behavioral and sociocultural underpinnings of normal behavior and the causes and consequences of neuropsychiatric disorders. In addition to conducting fundamental research, institute faculty seek to develop effective treatments for neurological and psychiatric disorders, improve access to mental health services and shape national health policy regarding neuropsychiatric disorders.

For more news, visit the UCLA Newsroom or follow us on Twitter.
Media Contact:
Mark Wheeler
(310) 794-2265
mwheeler@mednet.ucla.edu


Media Contact
Mark Wheeler
(310) 794-2265
mwheeler@mednet.ucla.edu



Latest News

Health and Behavior
Low-income undocumented adults are largely locked out of health care in California, study finds
02/19/2019
Nine in 10 lack insurance.

Health and Behavior
UCLA faculty voice: Adolescents have a fundamental need to contribute
02/19/2019
No longer children but not yet adults, adolescents need opportunities to learn and prepare for their entrance into the broader society.

Health and Behavior
Sexually transmitted infections are on the rise. Here’s what you need to know to protect yourself
02/14/2019
In a Q&A, UCLA’s Dr. Leena Nathan explains which infections sexually active people are more likely to be exposed to and to contract.

Health and Behavior
Electrical activity early in fruit flies’ brain development could shed light on how neurons wire the brain
02/12/2019
A study by UCLA neuroscientists suggests that the signals could help neurons find each other to form networks.

Health and Behavior
For recurrent glioblastoma, immunotherapy before surgery appears to help more than afterward
02/11/2019
“We now have a rational and logical way to develop immunotherapies going forward and a clinical development process for doing it,” said UCLA's Dr. Timothy Cloughesy.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest Follow us on Flickr Follow us on Sharecare

Sign in to myUCLAhealth